SomaGenics focus on developing novel RNA-centred approaches to address important aspects of diagnostic detection of miRNAs including bias, sequencing costs, direct isolation and quantification of circulating miRNAs from plasma samples and detection of low-abundant miRNAs. Their core competencies include RNA molecules as therapeutic agents, drug targets and biomarkers as well as RNA analysis tools.
The SomaGenics portfolio consists of real-time qPCR assays for miRNAs and other small RNAs (total RNA & biofluids) and sequencing library preparation kits for miRNAs and small RNAs for next-generation sequencing (NGS) compatible with Illumina® technology. Theses assays are also available as custom services.
To discuss a custom project, please contact our SomaGenics specialist.